ondansetron has been researched along with Leiomyosarcoma in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Leiomyosarcoma: A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of ondansetron has led to the widespread use of this medication in the treatment of nausea and vomiting caused by cancer chemotherapy and radiation therapy." | 3.69 | Anaphylactoid reactions associated with ondansetron. ( Kossey, JL; Kwok, KK, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kossey, JL | 1 |
| Kwok, KK | 1 |
1 other study available for ondansetron and Leiomyosarcoma
| Article | Year |
|---|---|
Anaphylactoid reactions associated with ondansetron.
Topics: Adult; Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cis | 1994 |